Reset osmostat syndrome — when hyponatremia become «a normal»: diagnostics, case report

Reset osmostat syndrome (ROS) is characterized by a change of normal plasma osmolality threshold (decrease or increase), which leads to chronic dysnatremia (hypo- or hypernatremia). We have described a clinical case of ROS and chronic hyponatremia in a patient with chordoid glioma of the III ventricle. It is known that the patient had previously been diagnosed with hyponatremia (131–134 mmol/l). She has not hypothyroidism and hypocorticism. There is normal filtration function of the kidneys was (CKD-EPI 91.7 ml/mi/1,73m²). Urine osmolality and sodium level were studied to exclude of concentration kidney function disorder. During first three days after removal of the tumor of the third ventricle (chordoid glioma, WHO Grade II), the sodium level decreased to 119 mmol/l. Repeated infusions of 200–300 ml hypertonic 3% sodium chloride solution, gluco- and mineralocorticoid therapy was ineffective, increasing plasma sodium levels by 2–3 mmol/l with the return to the initial level during 6–8 hours. Hypopituitary disorders did not develop after surgery. With further observation, the sodium level remained within 126–129 mmol/l for 6 months after surgery. The water load test make exclude the classic syndrome of inappropriate secretion of antidiuretic hormone, and confirmed the diagnosis of RSO. Because of absence of clinical symptoms associated with hyponatremia, no medical correction was required, patient was recommended to clinical follow-up.

1. Peng Goh K. Water and sodium balance management of hyponatremia. Am Fam Physician. 2004;69(10):2387-2394.

2. Milionis HJ, Liamis GL, Elisaf MS. The hyponatremic patient: A systematic approach to laboratory diagnosis. Nutr Clin Pract. 2003;18(1):104-105. doi: https://doi.org/10.1177/0115426503018001104c

3. Feder J, Gomez J, Serra-Aguirre F, Musso C. Reset osmostat: Facts and controversies. Indian J Nephrol. 2019;29(4):232. doi: https://doi.org/10.4103/ijn.IJN_307_17

4. Rigueto LG, Santiago HM, Hadad DJ, et al. The “new normal” osmotic threshold: Osmostat reset. Clin Nephrol. 2022;10(2196-5293):11-15. doi: https://doi.org/10.5414/CNCS110740

5. Hannon MJ, Thompson CJ. The syndrome of inappropriate antidiuretic hormone: prevalence, causes and consequences. Eur J Endocrinol. 2010;162(S1):S5-S12. doi: https://doi.org/10.1530/EJE-09-1063

6. Zerbe R, Stropes L, Robertson G. Vasopressin function in the syndrome of inappropriate antidiuresis. Annu Rev Med. 1980;31(1):315-327. doi: https://doi.org/10.1146/annurev.me.31.020180.001531

7. Robertson GL. Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis. Am J Med. 2006;119(7):S36-S42. doi: https://doi.org/10.1016/j.amjmed.2006.05.006

8. Feldman BJ, Rosenthal SM, Vargas GA, et al. Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med. 2005;352(18):1884-1890. doi: https://doi.org/10.1056/NEJMoa042743

9. Makazan NV., Zubkova NA, Tiulpakov AN. A case of nephrogenic syndrome of inappropriate antidiuresis caused by a mutation of the vasopressin type 2 receptor. Problems of Endocrinology. 2017;63(2):106-109. doi: https://doi.org/10.14341/probl2017632106-109

10. Vale BM, Morais S, Mesquita J, Mimoso G. Reset osmostat: a rare cause of hyponatraemia. BMJ Case Rep. 2015:bcr2013009111. doi: https://doi.org/10.1136/bcr-2013-009111

11. Kahn T. Reset osmostat and salt and water retention in the course of severe hyponatremia. medicine. 2003;82(3):170-176. doi: https://doi.org/10.1097/01.md.0000076007.64510.15

12. Leggott J, Almond D. Reset osmostat in a 47-year-old woman with cerebral palsy. J Am Board Fam Pract. 2001;14(4):317-319.

13. Sterns RH. Treatment of hyponatremia: Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) and reset osmostat. UpToDate. 2022.

14. Arutiunov GP, Dragunov DO, Sokolova AV, Arutiunov AG. Fraktsionnaia ekskretsiia mochevoĭ kisloty kak al’ternativnyĭ marker nizkogo urovnia natriĭureza. Klinicheskaia nefrologiia. 2014;(5):20-24. (In Russ.)].

15. Pathophysiology. In: Alpern RJ, Hebert SC, editors. Seldin and Giebisch’s The Kidney (Fourth Edition). 2008. Vol. 2. P. 2113-2141.

16. Pigarova EA. Pervichnye i vtorichnye sindromy gipo- i gipernatriemii v endokrinologii, ikh sovremennaia diagnostika i lechenie. [dissertation] Moscow: FGBU Natsional’nyi meditsinskii issledovatel’skii tsentr endokrinologii MZ RF; 2019. (In Russ.).